Cipher Pharmaceuticals Inc.
CPH.TO
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 11.82M | 10.37M | 5.30M | 5.87M | 4.92M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.82M | 10.37M | 5.30M | 5.87M | 4.92M |
| Cost of Revenue | 5.13M | 1.97M | 1.11M | 1.06M | 955.00K |
| Gross Profit | 6.69M | 8.40M | 4.20M | 4.81M | 3.97M |
| SG&A Expenses | 4.85M | 4.61M | 1.32M | 1.47M | 1.29M |
| Depreciation & Amortization | 1.51M | 1.93M | 292.00K | 289.00K | 273.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.49M | 8.50M | 2.72M | 2.81M | 2.55M |
| Operating Income | 334.00K | 1.87M | 2.59M | 3.06M | 2.37M |
| Income Before Tax | -2.85M | 326.00K | 2.52M | 2.97M | 3.68M |
| Income Tax Expenses | -6.20M | 43.00K | -480.00K | -1.96M | -3.97M |
| Earnings from Continuing Operations | 3.34M | 283.00K | 3.00M | 4.92M | 7.66M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.34M | 283.00K | 3.00M | 4.92M | 7.66M |
| EBIT | 334.00K | 1.87M | 2.59M | 3.06M | 2.37M |
| EBITDA | 1.67M | 3.80M | 2.88M | 3.34M | 2.55M |
| EPS Basic | 0.13 | 0.01 | 0.12 | 0.21 | 0.32 |
| Normalized Basic EPS | -0.05 | 0.05 | 0.07 | 0.08 | 0.09 |
| EPS Diluted | 0.13 | 0.01 | 0.12 | 0.20 | 0.30 |
| Normalized Diluted EPS | -0.05 | 0.05 | 0.07 | 0.08 | 0.09 |
| Average Basic Shares Outstanding | 25.72M | 25.17M | 24.11M | 23.99M | 24.26M |
| Average Diluted Shares Outstanding | 25.72M | 25.69M | 24.57M | 24.40M | 24.78M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |